Cargando…
Unilateral Intrastriatal 6-Hydroxydopamine Lesion in Mice: A Closer Look into Non-Motor Phenotype and Glial Response
Parkinson’s disease (PD) is a prevalent movement disorder characterized by the progressive loss of dopaminergic neurons in substantia nigra pars compacta (SNpc). The 6-hydroxydopamine (6-OHDA) lesion is still one of the most widely used techniques for modeling Parkinson’s disease (PD) in rodents. De...
Autores principales: | Mendes-Pinheiro, Bárbara, Soares-Cunha, Carina, Marote, Ana, Loureiro-Campos, Eduardo, Campos, Jonas, Barata-Antunes, Sandra, Monteiro-Fernandes, Daniela, Santos, Diogo, Duarte-Silva, Sara, Pinto, Luísa, José Salgado, António |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584172/ https://www.ncbi.nlm.nih.gov/pubmed/34768962 http://dx.doi.org/10.3390/ijms222111530 |
Ejemplares similares
-
Antioxidant Effect of Alpha-Lipoic Acid in 6-Hydroxydopamine Unilateral Intrastriatal Injected Rats
por: Andreeva-Gateva, Pavlina, et al.
Publicado: (2020) -
Longitudinal assessment of motor function following the unilateral intrastriatal 6-hydroxydopamine lesion model in mice
por: Sun, Xiuping, et al.
Publicado: (2022) -
Paeonol Protection Against Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson’s Disease
por: Ghalami, Jamileh, et al.
Publicado: (2021) -
Treating Parkinson’s Disease with Human Bone Marrow Mesenchymal Stem Cell Secretome: A Translational Investigation Using Human Brain Organoids and Different Routes of In Vivo Administration
por: Mendes-Pinheiro, Bárbara, et al.
Publicado: (2023) -
Treatment with a Substance P Receptor Antagonist Is Neuroprotective in the Intrastriatal 6-Hydroxydopamine Model of Early Parkinson's Disease
por: Thornton, Emma, et al.
Publicado: (2012)